On Wednesday, Abbott stock experienced fluctuations after the major healthcare company reported an adjusted income of 98 cents per share on $10 billion in sales for the first quarter. This surpassed projections by The Street, which had estimated earnings of 95 cents per share and $9.88 billion in sales, according to FactSet.
During the same period the previous year, Abbott Laboratories (ABT) had earned $1.03 per share and reported $9.75 billion in sales. Looking ahead, Abbott narrowed its earnings guidance range for the year to between $4.55 and $4.70. Analysts are projecting earnings per share of $4.62. The company’s second-quarter guidance fell slightly short of expectations, with a range of $1.08 to $1.12, while consensus views anticipate $1.12.
In premarket trading on the stock market, Abbott’s stock initially rose by more than 2%, but then declined to a 0.7% loss. Shares are currently forming a flat base with a buy point at 121.64, as indicated by MarketSurge.com
The Arab League met in Manama to discuss regional issues and call for a peace…
Since 2011, NFL teams have been signing their draft picks before Memorial Day. This has…
In 2021, four exceptional scientists from Australia have been inducted into the prestigious Royal Society.…
In New Jersey, law enforcement and mental health professionals are collaborating on the ARRIVE Together…
Toshiba has recently announced that they will be cutting up to 4,000 jobs in Japan…
After more than three decades of operation, the iconic Mirage Hotel and Casino on the…